206 related articles for article (PubMed ID: 24930750)
1. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma.
Metgud R; Bajaj S
J Oral Sci; 2014 Jun; 56(2):135-42. PubMed ID: 24930750
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
[No Abstract] [Full Text] [Related]
3. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
4. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
5. Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.
Kaur J; Politis C; Jacobs R
Clin Oral Investig; 2016 Mar; 20(2):315-9. PubMed ID: 26077895
[TBL] [Abstract][Full Text] [Related]
6. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
Rai B; Kaur J; Jacobs R; Singh J
J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
[TBL] [Abstract][Full Text] [Related]
8. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S
J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
[TBL] [Abstract][Full Text] [Related]
9. A new and preliminary three-dimensional perspective: proteomes of optimization between OSCC and OLK.
He H; Sun G; Ping F; Cong Y
Artif Cells Blood Substit Immobil Biotechnol; 2011 Feb; 39(1):26-30. PubMed ID: 20932085
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of salivary metabolomics in oral leukoplakia and oral squamous cell carcinoma.
Sridharan G; Ramani P; Patankar S; Vijayaraghavan R
J Oral Pathol Med; 2019 Apr; 48(4):299-306. PubMed ID: 30714209
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of salivary endothelin-1 levels in oral squamous cell carcinoma and oral leukoplakia.
Hoffmann RR; Yurgel LS; Campos MM
Regul Pept; 2011 Jan; 166(1-3):55-8. PubMed ID: 20727373
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
Ganavi BS; Patil S; Rao RS
J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
[TBL] [Abstract][Full Text] [Related]
13. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
14. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma.
Korde SD; Basak A; Chaudhary M; Goyal M; Vagga A
Oncology; 2011; 80(5-6):382-9. PubMed ID: 21829039
[TBL] [Abstract][Full Text] [Related]
15. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of ethanol-induced protein adducts in oral leukoplakia (pre-cancer) and cancer.
Warnakulasuriya S; Parkkila S; Nagao T; Preedy VR; Pasanen M; Koivisto H; Niemelä O
J Oral Pathol Med; 2008 Mar; 37(3):157-65. PubMed ID: 18251940
[TBL] [Abstract][Full Text] [Related]
17. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients.
Gokul S; Patil VS; Jailkhani R; Hallikeri K; Kattappagari KK
Oral Dis; 2010 Jan; 16(1):29-33. PubMed ID: 19656315
[TBL] [Abstract][Full Text] [Related]
18. Estimation of salivary lactate dehydrogenase in oral leukoplakia and oral squamous cell carcinoma: a biochemical study.
Patel S; Metgud R
J Cancer Res Ther; 2015; 11(1):119-23. PubMed ID: 25879348
[TBL] [Abstract][Full Text] [Related]
19. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
[TBL] [Abstract][Full Text] [Related]
20. Oxidant-antioxidant status in patients with oral squamous cell carcinomas at different intraoral sites.
Subapriya R; Kumaraguruparan R; Ramachandran CR; Nagini S
Clin Biochem; 2002 Sep; 35(6):489-93. PubMed ID: 12413611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]